Cargando…

Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells

Head and neck cancer (HNC) has frequently an aggressive course for the development of resistance to standard chemotherapy. Thus, the use of innovative therapeutic drugs is being assessed. Bortezomib is a proteasome inhibitor with anticancer effects. In vitro antitumoral activity of Bortezomib was in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benvenuto, Monica, Ciuffa, Sara, Focaccetti, Chiara, Sbardella, Diego, Fazi, Sara, Scimeca, Manuel, Tundo, Grazia Raffaella, Barillari, Giovanni, Segni, Maria, Bonanno, Elena, Manzari, Vittorio, Modesti, Andrea, Masuelli, Laura, Coletta, Massimo, Bei, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463577/ https://www.ncbi.nlm.nih.gov/pubmed/34561494 http://dx.doi.org/10.1038/s41598-021-98450-6

Ejemplares similares

Curcumin Enhances the Antitumoral Effect Induced by the Recombinant Vaccinia Neu Vaccine (rV-neuT) in Mice with Transplanted Salivary Gland Carcinoma Cells
por: Focaccetti, Chiara, et al.
Publicado: (2020)

Polyphenols as Immunomodulatory Compounds in the Tumor Microenvironment: Friends or Foes?
por: Focaccetti, Chiara, et al.
Publicado: (2019)

Polyphenol-Mediated Autophagy in Cancer: Evidence of In Vitro and In Vivo Studies
por: Benvenuto, Monica, et al.
Publicado: (2020)

Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo
por: Bei, Roberto, et al.
Publicado: (2022)

Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo
por: Benvenuto, Monica, et al.
Publicado: (2023)

Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution
por: Sbardella, Diego, et al.
Publicado: (2015)

Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug
por: Tundo, Grazia Raffaella, et al.
Publicado: (2022)

Dexamethasone Downregulates Autophagy through Accelerated Turn-Over of the Ulk-1 Complex in a Trabecular Meshwork Cells Strain: Insights on Steroid-Induced Glaucoma Pathogenesis
por: Sbardella, Diego, et al.
Publicado: (2021)

Effects of a natural multi-component compound formulation on the growth, morphology and extracellular matrix production of human adult dermal fibroblasts
por: Benvenuto, Monica, et al.
Publicado: (2019)

Cationic porphyrins are tunable gatekeepers of the 20S proteasome
por: Santoro, Anna M., et al.
Publicado: (2016)

Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?
por: Barillari, Giovanni, et al.
Publicado: (2021)

A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose
por: Sbardella, Diego, et al.
Publicado: (2022)

The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
por: Tundo, G.R., et al.
Publicado: (2020)

Effects of Polyphenols on Oxidative Stress-Mediated Injury in Cardiomyocytes
por: Mattera, Rosanna, et al.
Publicado: (2017)

PlGF Immunological Impact during Pregnancy
por: Albonici, Loredana, et al.
Publicado: (2020)

Modulation of the 20S Proteasome Activity by Porphyrin Derivatives Is Steered through Their Charge Distribution
por: Persico, Marco, et al.
Publicado: (2022)

Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion
por: Lucarini, Valeria, et al.
Publicado: (2023)

Bortezomib Amplifies Effect on Intracellular Proteasomes by Changing Proteasome Structure()
por: Pitcher, David S., et al.
Publicado: (2015)

The resistance mechanisms of proteasome inhibitor bortezomib
por: Lü, Shuqing, et al.
Publicado: (2013)

In Vitro and in Vivo Antitumoral Effects of Combinations of Polyphenols, or Polyphenols and Anticancer Drugs: Perspectives on Cancer Treatment
por: Fantini, Massimo, et al.
Publicado: (2015)

Somatostatin Modulates Insulin-Degrading-Enzyme Metabolism: Implications for the Regulation of Microglia Activity in AD
por: Tundo, Grazia, et al.
Publicado: (2012)

Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma
por: Palumbo, Camilla, et al.
Publicado: (2023)

Electrostatic Map Of Proteasome α-Rings Encodes The Design of Allosteric Porphyrin-Based Inhibitors Able To Affect 20S Conformation By Cooperative Binding
por: Dato, Antonio Di, et al.
Publicado: (2017)

Cooperative Binding of the Cationic Porphyrin Tris-T4 Enhances Catalytic Activity of 20S Proteasome Unveiling a Complex Distribution of Functional States
por: Santoro, Anna Maria, et al.
Publicado: (2020)

The Potential Protective Effects of Polyphenols in Asbestos-Mediated Inflammation and Carcinogenesis of Mesothelium
por: Benvenuto, Monica, et al.
Publicado: (2016)

Resveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomas
por: Masuelli, Laura, et al.
Publicado: (2014)

Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
por: Kraus, M, et al.
Publicado: (2013)

Erratum to “Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients”
por: Scimeca, Manuel, et al.
Publicado: (2019)

Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients
por: Scimeca, Manuel, et al.
Publicado: (2018)

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
por: Cifaldi, Loredana, et al.
Publicado: (2023)

Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy
por: Boccadoro, Mario, et al.
Publicado: (2005)

Proteasome Inhibitor Bortezomib Ameliorates Intestinal Injury in Mice
por: Yanaba, Koichi, et al.
Publicado: (2012)

Alterations of the Intracellular Peptidome in Response to the Proteasome Inhibitor Bortezomib
por: Gelman, Julia S., et al.
Publicado: (2013)

Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients
por: Benvenuto, Monica, et al.
Publicado: (2015)

Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib
por: Steverding, Dietmar, et al.
Publicado: (2009)

Metformin Induces Resistance of Cancer Cells to the Proteasome Inhibitor Bortezomib
por: Schlesser, Camille, et al.
Publicado: (2022)

Enhancement of Neuroblastoma NK-Cell-Mediated Lysis through NF-kB p65 Subunit-Induced Expression of FAS and PVR, the Loss of Which Is Associated with Poor Patient Outcome
por: Brandetti, Elisa, et al.
Publicado: (2021)

In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors
por: Benvenuto, Monica, et al.
Publicado: (2016)

Effect of the BH3 Mimetic Polyphenol (–)-Gossypol (AT-101) on the in vitro and in vivo Growth of Malignant Mesothelioma
por: Benvenuto, Monica, et al.
Publicado: (2018)

Proteasome inhibition by bortezomib: A left hook and a right punch
por: Roelofs, Jeroen
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_aj44ufedhenpiubd66ad3s0kd7